Abstract 26P
Background
AR and ER play important roles in various processes in prostate. However, the role of androgens, estrogens and their receptors in regulating CSC phenotype in PCa is controversial. The study assessed characteristics of AR and ER alpha (ERα) and beta (ERβ) subtypes expression in association with CSC markers CD133 and CD44.
Methods
56 radical prostatectomy specimens were studied. Double immunofluorescence was used to stain ERα and ERβ, AR, CD133 and CD44 on consecutive slides. Staining was assessed semiquantitatively. AR and ER were evaluated separately in tumor epithelium and stroma in 3-15 random non-crossing high power fields (HPF, x400) per case with calculation of total staining score (TSS) by multiplication of scores for proportion of stained nuclei and intensity. For CD133 only presence of staining was analyzed, and for CD44 – staining intensity.
Results
Median (interquartile range) TSS for CD133+ (65.4%) and CD133- (34.6%) cases for different receptors are shown in the table. Table: 26P
CD133+ | CD133- | pMann-Whitney | |
AR | 1.64 (1.2-3.0) | 3.0 (2.0-4.6) | 0.025 |
ERα epith | 0.5 (0.1-1.0) | 0.5 (0.17-1.10) | 0.91 |
ERα stroma | 1.0 (0.57-1.82) | 1.4 (0.6-2.33) | 0.63 |
ERβ epith | 5.7 (1.88-7.0) | 4.8 (2.5-6.71) | 0.74 |
ERβ stroma | 3.67 (2.0-6.0) | 3.71 (1.1-6.5) | 0.65 |
AR appeared to be lower in CD133+ cases, that possibly means that lower AR levels and less dependence on androgen signaling may lead to CSC phenotype. No significant correlations were found between CD44 intensity and all AR and ER characteristics (pSpearman>0.05). Correlations between AR and ERs levels were assessed separately in CD133+ and CD133- cases. Stromal ERα and ERβ; ERβ in stroma and epithelium were significantly correlated in both groups, but correlation between ERα and ERβ in epithelium was seen only in CD133+ cases (r=0.49, pSpearman<0.05), so possibly presence of both receptors in PCa cells is important for the development of CSC features as a result of hormonal stimulation.
Conclusions
Levels of AR were lower in CD133+ PCa, and in these cases also correlation between ER subtypes in cancer cells was found. This may assume that CSC features are obtained in PCa that is less sensitive to androgens, but responsive to estrogens, and relative levels of ERα and ERβ are important.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
M. Puchinskaya.
Funding
Belarusian Republican Foundation for Fundamental Research, grants No. M14M-143, M19M-123.
Disclosure
M. Puchinskaya: Financial Interests, Personal, Invited Speaker: Roche.
Resources from the same session
10P - An adapted CGP-based model to interpret POLE mutations in endometrial cancer
Presenter: Rita Trozzi
Session: Cocktail & Poster Display session
Resources:
Abstract
11P - Reconstructing tumour evolution of single cells using both somatic mutations and copy-number alterations
Presenter: Rija Zaidi
Session: Cocktail & Poster Display session
Resources:
Abstract
12P - Swiss-PO: Molecular modelling for precision oncology
Presenter: Fanny Krebs
Session: Cocktail & Poster Display session
Resources:
Abstract
13P - A novel algorithm for predicting variant detectability in oncogenomic analysis
Presenter: Alper Akkuş
Session: Cocktail & Poster Display session
Resources:
Abstract
14P - expHRD: An algorithm for the transcriptome-based estimation of homologous recombination deficiency score
Presenter: Jin-Ku Lee
Session: Cocktail & Poster Display session
Resources:
Abstract
15P - ClinBioNGS: An integrated clinical bioinformatics pipeline for the analysis of somatic NGS cancer panels
Presenter: Xavier Sole
Session: Cocktail & Poster Display session
Resources:
Abstract
16P - Investigation of c-MYC role in DNA-PK-mediated activation of STING pathway in SCLC
Presenter: Caterina de Rosa
Session: Cocktail & Poster Display session
Resources:
Abstract
17P - NRF2 activation promotes HER2-targeted tolerance and resistance in oesophageal adenocarcinoma through metabolic reprogramming to glutathione
Presenter: Wei Zhang
Session: Cocktail & Poster Display session
Resources:
Abstract
18P - AURKB inhibition radiosensitises NSCLC by altering mitotic fate
Presenter: Kathryn Egerton
Session: Cocktail & Poster Display session
Resources:
Abstract
19P - Stratified control study on neuroendocrine differentiation and potential clinical markers in patients with limited-stage small-cell lung cancer
Presenter: Li Liu
Session: Cocktail & Poster Display session
Resources:
Abstract